{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "inhibits_modification",
    "modifications" : [ {
      "modification_type" : "phosphorylation"
    } ],
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "be:ERK",
      "entity_text" : "ERK",
      "entity_type" : "family"
    },
    "is_direct" : false,
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ07360",
      "entity_text" : "LY3009120",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "We also found that LY3009120 inhibited phosphorylation of ERK more strongly than Vemurafenib and even suppressed expressions of BRAF and HRAS, another unique property of LY3009120 as reported in melanoma XREF_BIBR.",
  "reading_complete" : "2020-08-02T16:51:18Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T16:49:24Z",
  "trigger" : "inhibited",
  "evidence" : [ "LY3009120 inhibited phosphorylation of ERK" ],
  "pmc_id" : "5381260",
  "score" : 0
}